Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

This publication has 24 references indexed in Scilit:

• NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis: A Sufficient Reason to Avoid Gadolinium-Based Contrast in All Patients with Renal Impairment?
  Seminars in Dialysis, 2008
• New Insights into Nephrogenic Systemic Fibrosis
  Journal of the American Society of Nephrology, 2007
• Nephrogenic Systemic Fibrosis, Gadolinium, and Iron Mobilization
  New England Journal of Medicine, 2007
• Gadolinium and nephrogenic systemic fibrosis
  Kidney International, 2007
• Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
  Magnetic Resonance Materials in Physics, Biology and Medicine, 2007
• THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY
  Neurosurgery, 2007
• Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis Patients
  American Journal of Nephrology, 2005
• Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial
  Journal of Magnetic Resonance Imaging, 2004
• Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours
  Neuropathology and Applied Neurobiology, 2004
• Delivery of Virus-sized Iron Oxide Particles to Rodent CNS Neurons
  Neurosurgery, 1994